BBSRC IAA: Validation of the epigenetic reader BPTF as an oncotarget for small molecule inhibitor development for the treatment of melanoma

Project Details

Short titleBBSRC IAA: Validation of the epigenetic reader BPTF as an oncotarget for small molecule inhibitor development for the treatment of melanoma
StatusFinished
Effective start/end date1/01/19 → 31/10/20

Funding

  • Biotechnology & Biological Sciences Research Council